ScholarIQanswers from OpenAlex & ORCID
Marco Onofrj
ResearcherPublications, citations & collaboration network
Marco Onofrj is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marco Onofrj have?
ScholarIQindexed works
Marco Onofrj has 555 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marco Onofrj have?
ScholarIQcitation count
Marco Onofrj has 16,802 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marco Onofrj?
ScholarIQh-index
Marco Onofrj has an h-index of 70 in OpenAlex.
What is the i10-index of Marco Onofrj?
ScholarIQi10-index
Marco Onofrj has an i10-index of 290 in OpenAlex.
What is the ORCID of Marco Onofrj?
ScholarIQorcid
The ORCID for Marco Onofrj is on the source record.
What is the OpenAlex record for Marco Onofrj?
ScholarIQopenalex
The OpenAlex for Marco Onofrj is on the source record.
What are the most-cited papers on Marco Onofrj?
ScholarIQmost cited works
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons
Claudio Babiloni, Katarzyna J. Blinowska, Laura Bonanni, Andrzej Cichocki, Willem de Haan, Claudio Del Percio, Bruno Dubois, Javier Escudero, Alberto Fernández, Giovanni B. Frisoni, Bahar Güntekin, Mihály Hajós, Harald Hampel, Emmanuel Ifeachor, Kerry Kilborn, Sanjeev Kumar, Kristinn Johnsen, Magnús Jóhannsson, Jaeseung Jeong, Fiona E. N. LeBeau, Roberta Lizio, Fernando Lopes da Silva, Fernando Maestú, William J. McGeown, Ian G. McKeith, Davide Vito Moretti, Flavio Nobili, John Olichney, Marco Onofrj, Jorge J. Palop, Michael J. Rowan, Fabrizio Stocchi, Zbigniew M Struzik, Heikki Tanila, Stefan Teipel, John‐Paul Taylor, Marco Weiergräber, Görsev Yener, Tracy L. Young‐Pearse, Wilhelmus Drinkenburg, Fiona Randall
A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule
Bengt Winblad, Jeffrey L. Cummings, Niels Andreasen, George T. Grossberg, Marco Onofrj, Carl Sadowsky, Stefanie Zechner, Jennifer Nagel, Roger Lane
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder
Giovanni Martinotti, Gianna Sepede, Francesco Gambi, Giuseppe Di Iorio, Domenico De Berardis, Marco Di Nicola, Marco Onofrj, Luigi Janiri, Massimo Di Giannantonio
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel
Claudio Babiloni, Xianghong Arakaki, Hamed Azami, Karim Bennys, Katarzyna J. Blinowska, Laura Bonanni, Ana Buján, María C. Carrillo, Andrzej Cichocki, Jaisalmer de Frutos‐Lucas, Claudio Del Percio, Bruno Dubois, Rebecca M. Edelmayer, Gary F. Egan, Stéphane Epelbaum, Javier Escudero, Alan C. Evans, Francesca R Farina, Keith N. Fargo, Alberto Fernández, Raffaele Ferri, Giovanni B. Frisoni, Harald Hampel, Michael G. Harrington, Vesna Jelić, Jaeseung Jeong, Yang Jiang, Maciej Kamiński, Voyko Kavcic, Kerry Kilborn, Sanjeev Kumar, Alice Lam, Lew Lim, Roberta Lizio, David López, Susanna Lopez, Brendan P. Lucey, Fernando Maestú, William J. McGeown, Ian G. McKeith, Davide Vito Moretti, Flavio Nobili, Giuseppe Noce, John Olichney, Marco Onofrj, Ricardo S. Osorio, Mario A. Parra, Tarek K. Rajji, Petra Ritter, Andrea Soricelli, Fabrizio Stocchi, Ioannis Tarnanas, John‐Paul Taylor, Stefan Teipel, Federico Tucci, Mitchell Valdés‐Sosa, Pedro A. Valdés‐Sosa, Marco Weiergräber, Görsev Yener, Bahar Güntekin